Spero Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Spero Therapeutics, Inc. (SPRO) had Lessee, Operating Lease, Liability, to be Paid, Year One of $1.96 million as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-03-26
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.96M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.75M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.69M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.36M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-31 | $1.96M 10-K · filed 2026-03-26 |
| 2024-12-31 | $1.75M 10-K · filed 2025-03-27 |
| 2022-12-31 | $1.69M 10-K · filed 2023-03-30 |
| 2021-12-31 | $1.36M 10-K · filed 2022-03-31 |
| 2020-12-31 | $947.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $947.00K 10-Q · filed 2020-11-05 |
| 2019-12-31 | $928.00K 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |